How much can I get from the blood pressure drug settlement?

Individual payout amounts depend on which drug you purchased, how much you spent, and how many people file claims. The three settlement funds total $15.26 million combined: Hetero Valsartan ($11.37M), Aurobindo Irbesartan ($2M), and Vivimed Losartan ($1.9M). Attorneys' fees, costs, and administration expenses will be deducted before distribution. Payouts are calculated pro rata based on your purchases.

Do I need proof to file a blood pressure drug settlement claim?

Documentation should be submitted to support your claim if possible. Your claim will be reviewed by the administrator. If your documentation is insufficient, the administrator may contact you for proof of purchase from your pharmacy. You are encouraged to provide pharmacy receipts or insurance records with your claim to prevent delays.

When is the deadline to file a blood pressure drug settlement claim?

June 2, 2026. Claims can be submitted online at SartanMedicationSettlement.com or mailed to the settlement administrator. This deadline applies to all three settlements (Hetero Valsartan, Aurobindo Irbesartan, and Vivimed Losartan).

Valsartan, Losartan, and Irbesartan Settlement -- $15.26 Million for Contaminated Blood Pressure Drugs

Q: Who qualifies for the valsartan, losartan, or irbesartan settlement?

You qualify if you are an individual in the United States who paid any amount for retail purchases of: (1) Valsartan manufactured by Hetero, sold between May 1 and July 31, 2018; (2) Irbesartan manufactured using Aurobindo's IC Route of Synthesis, purchased from January 1, 2016 to the present; or (3) Losartan sold under specific Vivimed National Drug Codes. You may qualify for one, two, or all three settlements depending on which drugs you purchased.

Q: What was wrong with these blood pressure drugs?

The lawsuit alleged that certain batches of generic valsartan, losartan, and irbesartan were manufactured using processes that created nitrosamine impurities (NDMA, NDEA, and NMBA), which are classified as probable human carcinogens. These impurities were introduced during the manufacturing of the active pharmaceutical ingredients. The defendants deny that the levels found were harmful or carcinogenic.

By Steve Levine

Valsartan Losartan Irbesartan Contaminated Blood Pressure Drug Class Action Settlement $15.26 Million NDMA NDEA Carcinogen 2026

Published: April 4, 2026

Claim Deadline: June 2, 2026

Combined Fund: $15.26 million (3 separate settlements)

Proof: Documentation encouraged but not always required

What Is This Settlement About?

Three separate class action settlements have been reached in a massive multidistrict litigation over contaminated blood pressure medications. The lawsuit alleged that certain generic versions of valsartan, losartan, and irbesartan were manufactured using processes that created nitrosamine impurities -- NDMA, NDEA, and NMBA -- which are classified as probable human carcinogens. The contamination led to a series of nationwide drug recalls starting in 2018.

These three settlements resolve the economic loss claims -- meaning they cover what consumers and insurers overpaid for drugs that were allegedly contaminated and should not have been sold. They do not cover personal injury or medical monitoring claims, which are being litigated separately in the same MDL.

All three defendants deny any wrongdoing and deny that the levels of nitrosamine impurities found in their products were harmful or carcinogenic.

Three Settlements, One Claim Form

There are three separate settlement funds from three different pharmaceutical companies, but they are all administered through one website with one claim deadline. Here is what each settlement covers:

Hetero — Valsartan ($11,365,490): Covers individuals who purchased valsartan finished drug formulations containing Hetero Process III valsartan API, sold between May 1, 2018 and July 31, 2018. For full details on the Hetero settlement, including how to check if your pills were made by Hetero, see our in-depth Hetero Valsartan settlement page.

Aurobindo — Irbesartan ($2,000,000): Covers individuals who purchased irbesartan finished drug formulations manufactured using Aurobindo's IC Route of Synthesis, purchased from January 1, 2016 to the present.

Vivimed — Losartan ($1,899,000): Covers individuals who purchased losartan finished drug formulations sold under specific Vivimed National Drug Codes (NDCs): 23155-644-09, 23155-644-10, 23155-645-03, 23155-645-09, 23155-645-10, 23155-646-03, 23155-646-09, and 23155-646-10.

You may qualify for one, two, or all three settlements depending on which drugs you purchased.

Who Qualifies?

You qualify if you are an individual in the United States, its territories, or possessions who paid any amount of money for retail purchases of any of the covered drugs during the relevant time periods. This includes copays, out-of-pocket payments, and any other amount you paid. The class also includes third-party payors like health insurers and welfare funds.

You do not qualify if you purchased these drugs only for resale, if you are a pharmacy benefit manager, or if you are a federal or state government entity (with limited exceptions for self-funded government employee benefit plans).

If you are not sure whether you purchased a covered drug, you can visit the settlement website and answer a few questions to check your eligibility, or call the settlement administrator.

Do I Need Proof?

Documentation should be submitted to support your claim if possible. Pharmacy receipts, insurance explanation of benefits statements, or prescription history records are all examples of documentation that could support your claim.

If you submit a claim without documentation, the administrator will review it and may contact you for proof of purchase from your pharmacy. Providing documentation upfront will help prevent delays in processing your claim. But the notice does not state that documentation is absolutely required -- it says "if possible."

How Do I File a Claim?

Submit your claim online at SartanMedicationSettlement.com or download a paper claim form and mail it to the settlement administrator. Your claim must be submitted online or postmarked by June 2, 2026.

When Will Payments Be Sent?

The final approval hearing is scheduled for June 30, 2026 at 10:00 AM at Courtroom 3D of the U.S. District Court for the District of New Jersey. If the court grants final approval and no appeals are filed, the settlement administrator will begin distributing payments after the effective date. The exact timing depends on the court's final approval order and how long claims processing takes.

How Do I Find Class Action Settlements?

Find all the latest class actions you can qualify for by getting notified of new lawsuits as soon as they are open to claims:

Official Settlement Notice (PDF)

Settlement Website: SartanMedicationSettlement.com

Submit Claim

Related Settlement Pages

• Hetero Valsartan Settlement ($11.37M) — In-depth guide to the largest of the three settlements, including how to check if your pills were made by Hetero, what NDMA is, and whether valsartan can cause cancer.

Sources

• Official Settlement Website -- SartanMedicationSettlement.com
• Court-authorized settlement notices, In re: Valsartan, Losartan, and Irbesartan Products Liability Litigation, Case No. 1:19-md-02875-RBK-SAK (D.N.J.)
• PR Newswire, "Class action settlements involving Hetero Valsartan, Aurobindo Irbesartan, and Vivimed Losartan medications" (April 2, 2026)

Filing Class Action Settlement Claims

Please note that your claim form will be rejected if you submit a settlement claim with any fraudulent information. By providing this information and your sworn statement of its veracity, you agree to do so under the penalty of perjury. If you are not sure whether you qualify, visit the class action administrator's website. OpenClassActions.com is a consumer advocacy and class action news site, and is not a class action administrator or a law firm.

For more class actions keep scrolling below.

Open Class Action Lawsuit and Class Action Settlement

DraftKings & FanDuel Addiction Lawsuits

Status: Open

Submit Claim

Kids Playing Roblox - Alleged Abuse

Pre-Qualify Here

Submit Claim

Acne Products Benzene Class Action Lawsuit

$990K Differin Acne Product Settlement

Deadline: May 19, 2026

Submit Claim

File a rebate form to get a coupon, refund, rebate, or payment from this class action settlement

$4.17M RevitaLash Conditioner Settlement

Deadline: April 20, 2026

Submit Claim

$87.5M Beef Prices Settlement

Deadline: June 30, 2026

Submit Claim

Dollar General Bait & Switch Settlement

Deadline: April 13, 2026

Submit Claim

Belkin Power Bank Settlement

Deadline: March 30, 2026

Submit Claim

New Dog Supplements NO Proof Required Open Class Action Lawsuit

Cosequin Dog Supplements Settlement

Deadline: July 21, 2026

Submit Claim

New Open Class Action Lawsuit and Investigation

Depo Provera Investigation

Deadline: Pending

Pre-Qualify

Blood Pressure Drug Settlement Summary
Status	Open — File Claim Now
Claim Deadline	June 2, 2026
Hetero Valsartan	$11,365,490
Aurobindo Irbesartan	$2,000,000
Vivimed Losartan	$1,899,000
Combined Total	$15,264,490
Final Hearing	June 30, 2026 at 10:00 AM (D.N.J.)
Website	Sartan Medication Settlement
Related	Hetero Valsartan In-Depth Guide ($11.37M)